Prestigious Award Recognizes Groundbreaking Body's Defenses Discoveries

This year's prestigious award in Physiology or Medicine has been granted for transformative findings that illuminate how the body's defense network targets dangerous pathogens while sparing the body's own cells.

Three renowned scientists—from Japan Shimon Sakaguchi and US scientists Mary Brunkow and Fred Ramsdell—received this honor.

Their work uncovered specialized "security guards" within the defense system that remove rogue defense cells capable of harming the body.

The findings are now paving the way for innovative treatments for immune disorders and cancer.

The winners will share a monetary award valued at 11 million SEK.

Crucial Findings

"Their work has been essential for comprehending how the immune system functions and the reason we don't all suffer from serious self-attack conditions," commented the chair of the Nobel Committee.

This trio's research explain a core question: In what way does the immune system protect us from countless invaders while keeping our own tissues intact?

The immune system uses white blood cells that scan for signs of infection, including pathogens and bacteria it has not met before.

These defenders employ detectors—known as receptors—that are generated by chance in a vast number of combinations.

That provides the defense network the ability to combat a wide array of invaders, but the randomness of the process inevitably produces immune cells that can attack the body.

Protectors of the Immune System

Scientists previously knew that a portion of these harmful defense cells were destroyed in the immune organ—where white blood cells develop.

The latest award honors the identification of regulatory T-cells—known as the immune system's "security guards"—which travel through the body to disarm other defenders that assault the healthy cells.

It is known that this process fails in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.

The Nobel panel stated, "These discoveries have laid the foundation for a new field of research and accelerated the development of innovative therapies, for instance for cancer and immune disorders."

Regarding cancer, regulatory T-cells block the system from fighting the growth, so studies are aimed at reducing their numbers.

In autoimmune diseases, trials are testing increasing T-reg cells so the body is not under attack. A similar approach could also be effective in minimizing the risks of transplanted organ rejection.

Pioneering Studies

Professor Shimon Sakaguchi, of Osaka University, conducted tests on rodents that had their thymus removed, causing autoimmune disease.

The researcher showed that injecting immune cells from other animals could stop the illness—implying there was a system for blocking defenders from harming the host.

Dr. Brunkow, affiliated with the a research center in a US city, and Fred Ramsdell, now at a biotech firm in a California city, were studying an inherited immune disorder in rodents and humans that led to the discovery of a genetic factor vital for the way T-regs operate.

"Their groundbreaking research has uncovered how the body's defenses is kept in check by regulatory T cells, stopping it from accidentally targeting the healthy cells," said a prominent physiology specialist.

"The work is a striking example of how fundamental biological study can have broad consequences for public health."